Hydration and Contrast-Induced Nephropathy in Primary Angioplasty
NCT00770614 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 450
Last updated 2012-05-08
Summary
The purpose of this study is to determine whether hydration with sodium bicarbonate is more effective than hydration with sodium chloride to prevent contrast induced nephropathy in patients undergoing Primary Coronary Intervention for Acute ST Elevation Myocardial Infarction.
Conditions
- Contrast Induced Nephropathy
Interventions
- DRUG
-
sodium bicarbonate solution
154 mEq/L in dextrose and H2O
- DRUG
-
Isotonic saline
0.9% sodium chloride
- DRUG
-
Placebo
Sponsors & Collaborators
-
Ospedale Misericordia e Dolce
lead OTHER
Principal Investigators
-
Mauro Maioli, MD · Ospedale Misericordia e Dolce, Prato
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-03-31
- Primary Completion
- 2008-06-30
- Completion
- 2008-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
NCT01160627 ·Status: COMPLETED ·Phase: NA
-
Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure
NCT00716001 ·Status: UNKNOWN ·Phase: PHASE4
-
The Use of Sodium Bicarbonate in the Prevention of Contrast Induced Nephropathy
NCT00494637 ·Status: TERMINATED ·Phase: NA
-
Prevention of Contrast Nephropathy During Diagnostic Coronary Angiogram or PCI With Hydratation Based on LEVDP
NCT00584350 ·Status: UNKNOWN ·Phase: PHASE4
-
Sodium Bicarbonate and N-Acetylcysteine for Nephroprotection in Acute Myocardial Infarction
NCT01218178 ·Status: COMPLETED
-
Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy
NCT01172353 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Sodium Bicarbonate Solution in Decreasing the Incidence of Contrast Induced Nephropathy (CIN)
NCT00514150 ·Status: COMPLETED ·Phase: PHASE3
-
Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy
NCT01093131 ·Status: WITHDRAWN ·Phase: PHASE4
-
COmbined N-acetylcysteine and Bicarbonate in PCI To Reduce Adverse Side Effect of contrasT
NCT00497328 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-Acetylcystein
NCT00463749 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography
NCT00950079 ·Status: UNKNOWN ·Phase: PHASE4
-
Contrast Nephropathy Prevention With N-Acetylcysteine in Acute Myocardial Infarction
NCT00237614 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride and N-acetylcysteine
NCT00353340 ·Status: COMPLETED ·Phase: NA
-
Aminophylline and Contrast Induced Nephropathy in Acute Myocardial Infarction
NCT01594489 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy
NCT00424320 ·Status: UNKNOWN ·Phase: PHASE3
-
The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy
NCT03627130 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease
NCT00930436 ·Status: TERMINATED ·Phase: PHASE3
-
Prevention of Contrast Renal Injury With Different Hydration Strategies
NCT01218828 ·Status: COMPLETED ·Phase: PHASE3
-
Preventing Contrast-induced Nephropathy: Evaluating Hydration Strategies and L-carnitine Administration
NCT01786824 ·Status: TERMINATED ·Phase: PHASE3
-
Prevention of Serious Adverse Events Following Angiography
NCT01467466 ·Status: COMPLETED ·Phase: PHASE3
-
Bicarbonate v Saline to Prevent Contrast Nephropathy
NCT00384995 ·Status: TERMINATED ·Phase: PHASE4
-
Dapagliflozin to Prevent the Incidence of Contrast Induced Nephropathy After Heart Catheterization and Percutaneous Coronary Intervention
NCT04806633 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Preventing contrAst Induced Nephropathy After TranscathEter Aortic Valve Replacement
NCT03121053 ·Status: UNKNOWN ·Phase: PHASE4
-
Intravenous High Dose NAC and Sodium Bicarbonate for the Prevention of Contrast-induced Acute Injury
NCT01612013 ·Status: COMPLETED ·Phase: NA
-
Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate
NCT00312117 ·Status: COMPLETED ·Phase: PHASE3